BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$487M |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$393M |
| 3 |
Microsoft
MSFT
|
+$380M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$349M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$312M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Salesforce
CRM
|
+$765M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$368M |
| 4 |
Eli Lilly
LLY
|
+$255M |
| 5 |
AGN
Allergan plc
AGN
|
+$225M |
Sector Composition
| 1 | Technology | 18.31% |
| 2 | Consumer Discretionary | 8.56% |
| 3 | Healthcare | 8.43% |
| 4 | Financials | 7.4% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1551
CareTrust REIT
CTRE
$7.62B
| $326K | ﹤0.01% |
18,993
-71,016
| -79% | -$1.22M |
|
1552
Werner Enterprises
WERN
$1.68B
| $326K | ﹤0.01% |
7,485
-129
| -2% | -$5.62K |
|
|
TGI
1553
DELISTED
Triumph Group
TGI
| $326K | ﹤0.01% |
36,147
+15,258
| +73% | +$137K |
|
1554
TEGNA Inc
TGNA
$3.39B
| $326K | ﹤0.01% |
29,229
-156,029
| -84% | -$1.74M |
|
1555
Chord Energy
CHRD
$5.96B
| $326K | ﹤0.01% |
434,139
-800,889
| -65% | -$601K |
|
1556
Ligand Pharmaceuticals
LGND
$3.23B
| $326K | ﹤0.01% |
4,666
-19,103
| -80% | -$1.33M |
|
|
GOL
1557
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
| $325K | ﹤0.01% |
+48,000
| New | +$325K |
|
1558
Evertec
EVTC
$2.14B
| $325K | ﹤0.01% |
11,557
-17,541
| -60% | -$493K |
|
1559
Post Holdings
POST
$5.7B
| $324K | ﹤0.01% |
5,651
+502
| +10% | +$28.8K |
|
1560
Casella Waste Systems
CWST
$5.79B
| $323K | ﹤0.01% |
6,195
-11,689
| -65% | -$609K |
|
1561
Companhia Siderúrgica Nacional
SID
$2.01B
| $323K | ﹤0.01% |
164,695
-84,899
| -34% | -$166K |
|
1562
MACOM Technology Solutions
MTSI
$9.82B
| $322K | ﹤0.01% |
9,381
-10,139
| -52% | -$348K |
|
1563
Associated Banc-Corp
ASB
$4.35B
| $321K | ﹤0.01% |
23,447
-64,991
| -73% | -$889K |
|
1564
Ericsson
ERIC
$26.4B
| $319K | ﹤0.01% |
34,304
-54,466
| -61% | -$507K |
|
1565
Strategic Education
STRA
$1.98B
| $318K | ﹤0.01% |
2,069
-6,944
| -77% | -$1.07M |
|
1566
EnerSys
ENS
$4B
| $317K | ﹤0.01% |
4,930
-4,301
| -47% | -$277K |
|
|
BDN
1567
Brandywine Realty Trust
BDN
$789M
| $316K | ﹤0.01% |
29,023
+3,865
| +15% | +$42.1K |
|
1568
Insmed
INSM
$30.8B
| $316K | ﹤0.01% |
11,473
-33,485
| -74% | -$922K |
|
|
DRNA
1569
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $316K | ﹤0.01% |
12,427
-24,749
| -67% | -$629K |
|
|
ENLC
1570
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $315K | ﹤0.01% |
129,293
+128,702
| +21,777% | +$314K |
|
1571
CNO Financial Group
CNO
$3.8B
| $315K | ﹤0.01% |
20,240
-10,746
| -35% | -$167K |
|
1572
Ollie's Bargain Outlet
OLLI
$8.06B
| $315K | ﹤0.01% |
3,226
+442
| +16% | +$43.2K |
|
|
CRC
1573
DELISTED
California Resources Corporation
CRC
| $314K | ﹤0.01% |
257,554
-10,570
| -4% | -$12.9K |
|
1574
National Presto Industries
NPK
$802M
| $314K | ﹤0.01% |
3,594
+1,479
| +70% | +$129K |
|
1575
Soleno Therapeutics
SLNO
$2.85B
| $313K | ﹤0.01% |
9,411
+83
| +0.9% | +$2.76K |
|